Research Article
Determination of Tumor Marker Screening for Lung Cancer Using ROC Curves
Table 1
Serum marker concentrations and age in patients with lung cancer and benign lung lesions and in healthy subjects.
| | Healthy | Lung cancer | P |
| Year | 54.82 ± 12.79 | 62.93 ± 11.12 | <0.001 | CEA (ng/mL) | 5.87 ± 3.20 | 37.43 ± 128.73 | <0.001 | CA125 (U/mL) | 13.95 ± 16.56 | 56.06 ± 138.34 | 0.003 | CY211 (ng/mL) | 13.95 ± 16.56 | 8.57 ± 31.12 | 0.023 | GRP (pg/ml) | 48.09 ± 27.11 | 95.52 ± 158.82 | <0.001 | NSE (ng/mL) | 14.15 ± 7.10 | 20.75 ± 30.19 | <0.001 |
| | Benign lung disease | Lung cancer | P |
| Year | 67.09 ± 14.28 | 62.93 ± 11.12 | <0.001 | CEA (ng/mL) | 5.85 ± 16.31 | 37.43 ± 128.73 | <0.001 | CA125 (U/mL) | 44.09 ± 106.99 | 56.06 ± 138.34 | 0.46 | CY211 (ng/mL) | 5.96 ± 26.21 | 8.57 ± 31.12 | 0.23 | GRP (pg/ml) | 57.88 ± 52.42 | 95.52 ± 158.82 | <0.001 | NSE (ng/mL) | 14.14 ± 10.74 | 20.75 ± 30.19 | <0.001 |
|
|